Multiple Myeloma Market Share

Statistics for the 2023 & 2024 Multiple Myeloma market share, created by Mordor Intelligence™ Industry Reports. Multiple Myeloma share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Multiple Myeloma Industry

The multiple myeloma market is fragmented and competitive with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are Karyopharm Therapeutic Inc., Sanofi S.A., Amgen Inc., Takeda Pharmaceutical Company, and Bristol-Myers Squibb Company, among other players.

Multiple Myeloma Market Leaders

  1. Bristol-Myers Squibb Company

  2. Takeda Pharmaceutical Company Limited

  3. Amgen Inc.

  4. Sanofi S.A.

  5. Karyopharm Therapeutics Inc.

*Disclaimer: Major Players sorted in no particular order

Multiple Myeloma Market - cl.png

Multiple Myeloma Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)